Inventory analysts at StockNews.com assumed protection on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Score) in a report issued on Monday. The brokerage units a “promote” score on the inventory.
Navidea Biopharmaceuticals Inventory Efficiency
Navidea Biopharmaceuticals inventory opened at $0.24